VRAX
Virax Biolabs Group Ltd

5,954
Mkt Cap
$2.85M
Volume
224,274.00
52W High
$3.10
52W Low
$0.31
PE Ratio
-0.31
VRAX Fundamentals
Price
$0.4267
Prev Close
$0.3837
Open
$0.4354
50D MA
$0.4623
Beta
0.69
Avg. Volume
14.25M
EPS (Annual)
-$1.62
P/B
0.47
Rev/Employee
$333.21
Loading...
Loading...
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
19

Frequently Asked Questions

What is Market Cap of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
What is the 52-week high for Virax Biolabs Group Ltd - Ordinary Shares - Class A?
What is the 52-week low for Virax Biolabs Group Ltd - Ordinary Shares - Class A?
What is Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price today?
What was Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
What is the 50-day moving average of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
How many employess does Virax Biolabs Group Ltd - Ordinary Shares - Class A has?

Latest VRAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.